Ondra Health vs PreventiveMD
Two GLP-1 desks, one scoreboard. We put Ondra Health and PreventiveMD head-to-head on the published Brief Score — the same six factors, scored the same way.
Ondra Health
The verdict
Ondra Health takes this head-to-head.
Ondra Health scores 87 to 74 on our six-factor Brief Score — A rare combination of a rock-bottom $93 semaglutide, brand-name access, LegitScript certification and all-50-state reach.
That doesn't make PreventiveMD a bad call — it's best for readers who want compounded glp-1s from $83/mo all-in with brand wegovy and zepbound upgrade paths. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Ondra Health | PreventiveMD | |
|---|---|---|
| Brief Score | 87/100 (B+) | 74/100 (C) |
| Semaglutide | $93/mo | From $83/mo (as low as, term not published, all-in, compounded) |
| Tirzepatide | $166/mo | From $97/mo (as low as, term not published, all-in, compounded) |
| Coverage | All 50 states | 36 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
Ondra Health: $93 sema / $166 tirz — the lowest accredited nationwide line we track; brand access + LegitScript.
PreventiveMD: New to the tracker on 1 August 2026, and read on the provider's own site rather than taken on trust: we checked https://www.preventivemd.com/protocols/tirzepatide on 2026-08-01 and this row reflects what that page says. The line we publish is From $83/mo (as low as, term not published, all-in, compounded). There is no earlier reading of ours to compare it against yet.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.